Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Luvesilocin [inn]
2. J64ju3z4q2
3. Chembl5425653
4. Schembl24168355
5. Schembl25425515
6. Iprocin Glutarate Monoester
7. Ft104
8. Re104
9. Ft-104
10. Re-104
11. 1-[3-[2-[bis(1-methylethyl)amino]ethyl]-1h-indol-4-yl] Pentanedioate
12. Pentanedioic Acid, 1-[3-[2-[bis(1-methylethyl)amino]ethyl]-1h-indol-4-yl] Ester
13. 2756001-39-3
| Molecular Weight | 374.5 g/mol |
|---|---|
| Molecular Formula | C21H30N2O4 |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 82.6 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 487 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
56
PharmaCompass offers a list of Luvesilocin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Luvesilocin manufacturer or Luvesilocin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Luvesilocin manufacturer or Luvesilocin supplier.
A Luvesilocin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Luvesilocin, including repackagers and relabelers. The FDA regulates Luvesilocin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Luvesilocin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Luvesilocin supplier is an individual or a company that provides Luvesilocin active pharmaceutical ingredient (API) or Luvesilocin finished formulations upon request. The Luvesilocin suppliers may include Luvesilocin API manufacturers, exporters, distributors and traders.
Luvesilocin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Luvesilocin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Luvesilocin GMP manufacturer or Luvesilocin GMP API supplier for your needs.
A Luvesilocin CoA (Certificate of Analysis) is a formal document that attests to Luvesilocin's compliance with Luvesilocin specifications and serves as a tool for batch-level quality control.
Luvesilocin CoA mostly includes findings from lab analyses of a specific batch. For each Luvesilocin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Luvesilocin may be tested according to a variety of international standards, such as European Pharmacopoeia (Luvesilocin EP), Luvesilocin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Luvesilocin USP).
